152 related articles for article (PubMed ID: 34556082)
1. The importance of choosing the right strategy to treat small cell carcinoma of the cervix: a comparative analysis of treatments.
Kawamura M; Koide Y; Murai T; Ishihara S; Takase Y; Murao T; Okazaki D; Yamaguchi T; Uchiyama K; Itoh Y; Kodaira T; Shibamoto Y; Mizuno M; Kikkawa F; Naganawa S
BMC Cancer; 2021 Sep; 21(1):1046. PubMed ID: 34556082
[TBL] [Abstract][Full Text] [Related]
2. The local treatment modalities in FIGO stage I-II small-cell carcinoma of the cervix are determined by disease stage and lymph node status.
Zhou J; Yang HY; Wu SG; He ZY; Lin HX; Sun JY; Li Q; Guo ZW
Cancer Med; 2016 Jun; 5(6):1108-15. PubMed ID: 26990881
[TBL] [Abstract][Full Text] [Related]
3. Prognostic risk factors for small cell carcinoma of the cervix and impact of platinum-based neoadjuvant chemotherapy.
Li X; Yang R; Jia Y; Zhou J; Ma D; Li S
Int J Gynaecol Obstet; 2015 Jul; 130(1):31-5. PubMed ID: 25890393
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.
Chan JK; Loizzi V; Burger RA; Rutgers J; Monk BJ
Cancer; 2003 Feb; 97(3):568-74. PubMed ID: 12548598
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and treatment comparison in small cell neuroendocrine cervical carcinoma.
Yin ZM; Yu AJ; Wu MJ; Zhu JQ; Zhang X; Chen JH; Yuan SH; Yu H
Eur J Gynaecol Oncol; 2014; 35(3):259-63. PubMed ID: 24984537
[TBL] [Abstract][Full Text] [Related]
6. A clinicopathological aspect of primary small-cell carcinoma of the uterine cervix: a single-centre study of 25 cases.
Li JD; Zhuang Y; Li YF; Feng YL; Hou JH; Chen L; Zhu AN; Wu QL; Yun JP
J Clin Pathol; 2011 Dec; 64(12):1102-7. PubMed ID: 21965825
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the impact of platinum-based combination chemotherapy in small cell cervical carcinoma: a multicenter retrospective study in Chinese patients.
Huang L; Liao LM; Liu AW; Wu JB; Cheng XL; Lin JX; Zheng M
BMC Cancer; 2014 Feb; 14():140. PubMed ID: 24575810
[TBL] [Abstract][Full Text] [Related]
8. Postoperative adjuvant radiation improves local control in surgically treated FIGO stage I-II small cell carcinoma of the cervix.
Shen T; Jiang YH; Zou YY; Qiu FF; Qiu XS; You KY
Radiat Oncol; 2019 Nov; 14(1):203. PubMed ID: 31722727
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and treatment comparison in small cell neuroendocrine carcinoma of the uterine cervix based on population analyses.
Lin LM; Lin Q; Liu J; Chu KX; Huang YX; Zhang ZK; Li T; Dai YQ; Li JL
Cancer Med; 2020 Sep; 9(18):6524-6532. PubMed ID: 32705800
[TBL] [Abstract][Full Text] [Related]
10. Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review.
Nagao S; Miwa M; Maeda N; Kogiku A; Yamamoto K; Morimoto A; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Sakuma T; Fujiwara K
Int J Gynecol Cancer; 2015 Sep; 25(7):1300-5. PubMed ID: 26166556
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
Lee JM; Lee KB; Nam JH; Ryu SY; Bae DS; Park JT; Kim SC; Cha SD; Kim KR; Song SY; Kang SB
Ann Oncol; 2008 Feb; 19(2):321-6. PubMed ID: 17962205
[TBL] [Abstract][Full Text] [Related]
12. Small cell carcinoma of the uterine cervix: a multi-institutional experience.
Li J; Ouyang Y; Tao Y; Wang L; Li M; Gao L; Cao X
Int J Gynecol Cancer; 2020 Feb; 30(2):174-180. PubMed ID: 31792086
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factors and Local Treatment Modalities of Small-Cell Carcinoma of the Cervix: An Analysis According to the International Federation of Gynecology and Obstetrics Stage.
Huang R; Gan Q; Cheng J
Cancer Manag Res; 2020; 12():3445-3456. PubMed ID: 32523375
[TBL] [Abstract][Full Text] [Related]
14. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients.
Cohen JG; Kapp DS; Shin JY; Urban R; Sherman AE; Chen LM; Osann K; Chan JK
Am J Obstet Gynecol; 2010 Oct; 203(4):347.e1-6. PubMed ID: 20579961
[TBL] [Abstract][Full Text] [Related]
15. Trends and predictors of survival for small cell carcinoma of the cervix uteri: A SEER population study.
Song T; Wan Q; Fang M; Zhan W; Xu H; Shou H
Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():35-41. PubMed ID: 32768799
[TBL] [Abstract][Full Text] [Related]
16. Chromogranin A (CgA) as poor prognostic factor in patients with small cell carcinoma of the cervix: results of a retrospective study of 293 patients.
Liao LM; Zhang X; Ren YF; Sun XY; Di N; Zhou N; Pan RK; Ma SH; Zhou LX
PLoS One; 2012; 7(4):e33674. PubMed ID: 22529895
[TBL] [Abstract][Full Text] [Related]
17. Small cell carcinoma of the uterine cervix: clinical outcome of concurrent chemoradiotherapy with a multidrug regimen.
Tokunaga H; Nagase S; Yoshinaga K; Tanaka S; Nagai T; Kurosawa H; Kaiho-Sakuma M; Toyoshima M; Otsuki T; Utsunomiya H; Takano T; Niikura H; Ito K; Yaegashi N
Tohoku J Exp Med; 2013 Jan; 229(1):75-81. PubMed ID: 23269283
[TBL] [Abstract][Full Text] [Related]
18. Natural history and outcome of neuroendocrine carcinoma of the cervix.
Margolis B; Tergas AI; Chen L; Hou JY; Burke WM; Hu JC; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2016 May; 141(2):247-254. PubMed ID: 26873865
[TBL] [Abstract][Full Text] [Related]
19. Influence of clinicopathological characteristics and comprehensive treatment models on the prognosis of small cell carcinoma of the cervix: A systematic review and meta-analysis.
Zhang Q; Xiong Y; Ye J; Zhang L; Li L
PLoS One; 2018; 13(4):e0192784. PubMed ID: 29641578
[TBL] [Abstract][Full Text] [Related]
20. The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
Zhao D; Sun S; Yang Z; Wang P; Qiu H
Neoplasma; 2024 Feb; 71(1):70-76. PubMed ID: 38215035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
